Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab.
Journal Information
Full Title: Ann Rheum Dis
Abbreviation: Ann Rheum Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests: DvdH and JB have received research funding and/or consulting fees from Centocor and/or Schering-Plough Research Institute. SV, CW, JCM, DB, JH and TG are employees of Centocor Research and Development, Inc. and own Johnson & Johnson stock."
Funding Disclosure
Evidence found in paper:
"Funding: This study was funded by Centocor Research and Development, Inc."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025